SwePub
Sök i LIBRIS databas

  Utökad sökning

onr:"swepub:oai:lup.lub.lu.se:b63f6124-2941-466e-aeda-6af9c2168cc5"
 

Sökning: onr:"swepub:oai:lup.lub.lu.se:b63f6124-2941-466e-aeda-6af9c2168cc5" > Mast Cell Activatio...

  • Kohno, RitsukoUniversity of Minnesota (författare)

Mast Cell Activation Disorder and Postural Orthostatic Tachycardia Syndrome : A Clinical Association

  • Artikel/kapitelEngelska2021

Förlag, utgivningsår, omfång ...

  • 2021

Nummerbeteckningar

  • LIBRIS-ID:oai:lup.lub.lu.se:b63f6124-2941-466e-aeda-6af9c2168cc5
  • https://lup.lub.lu.se/record/b63f6124-2941-466e-aeda-6af9c2168cc5URI
  • https://doi.org/10.1161/JAHA.121.021002DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:147551728URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:art swepub-publicationtype
  • Ämneskategori:ref swepub-contenttype

Anmärkningar

  • Background Recently there has been increased interest in a possible association between mast cell activation (MCA) disorder and postural orthostatic tachycardia syndrome (POTS). This study examined the frequency with which symptoms and laboratory findings suggesting MCA disorder occurred in patients diagnosed with POTS. Methods and Results Data were obtained from patients in whom symptoms and orthostatic testing were consistent with a POTS diagnosis. Individuals with <4 months symptom duration, evident ongoing inflammatory disease, suspected volume depletion, or declined consent were excluded. All patients had typical POTS symptoms; some, however, had additional nonorthostatic complaints not usually associated with POTS. The latter patients underwent additional testing for known MCA biochemical mediators including prostaglandins, histamine, methylhistamine, and plasma tryptase. The study comprised 69 patients who met POTS diagnostic criteria. In 44 patients (44/69, 64%) additional nonorthostatic symptoms included migraine, allergic complaints, skin rash, or gastrointestinal symptoms. Of these 44 patients, 29 (66%) exhibited at least 1 laboratory abnormality suggesting MCA disorder, and 11/29 patients had 2 or more such abnormalities. Elevated prostaglandins (n=16) or plasma histamine markers (n=23) were the most frequent findings. Thus, 42% (29/69) of patients initially diagnosed with POTS exhibited both additional symptoms and at least 1 elevated biochemical marker suggesting MCA disorder. Conclusions Laboratory findings suggesting MCA disorder were relatively common in patients diagnosed with POTS and who present with additional nonorthostatic gastrointestinal, cutaneous, and allergic symptoms. While solitary abnormal laboratory findings are not definitive, they favor MCA disorder being considered in such cases.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Cannom, David SPIH Health Good Samaritan Hospital,University of Southern California (författare)
  • Olshansky, BrianUniversity of Iowa (författare)
  • Xi, Shijun CindyUniversity of Southern California (författare)
  • Krishnappa, DarshanUniversity of Minnesota (författare)
  • Adkisson, Wayne OUniversity of Minnesota (författare)
  • Norby, Faye LCedars-Sinai Medical Center (författare)
  • Fedorowski, ArturKarolinska Institutet,Karolinska Institute,Lund University,Lunds universitet,Institutionen för kliniska vetenskaper, Malmö,Medicinska fakulteten,Kardiovaskulär forskning - hypertoni,Forskargrupper vid Lunds universitet,Department of Clinical Sciences, Malmö,Faculty of Medicine,Cardiovascular Research - Hypertension,Lund University Research Groups,Karolinska University Hospital(Swepub:lu)med-afr (författare)
  • Benditt, David GUniversity of Minnesota (författare)
  • University of MinnesotaPIH Health Good Samaritan Hospital (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Journal of the American Heart Association10:172047-9980

Internetlänk

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy